Once-Weekly Semaglutide in Adults with Overweight or Obesity

N Engl J Med. 2021 Jul 1;385(1):e4. doi: 10.1056/NEJMc2106918.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Glucagon-Like Peptides* / adverse effects
  • Humans
  • Obesity
  • Overweight* / complications

Substances

  • semaglutide
  • Glucagon-Like Peptides